Akari Therapeutics (AKTX) EBIT Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.21% |
| Dec 31, 2025 | 14.09% |
| Sep 30, 2025 | -97.42% |
| Jun 30, 2025 | 12.00% |
| Mar 31, 2025 | 6.48% |
| Dec 31, 2024 | -70.26% |
| Sep 30, 2024 | 1.25% |
| Jun 30, 2024 | -4.31% |
| Mar 31, 2024 | -246.94% |
| Dec 31, 2023 | -1.47% |
| Sep 30, 2023 | 3.44% |
| Jun 30, 2023 | 10.37% |
| Mar 31, 2023 | -1.31% |
| Jun 30, 2022 | 4.57% |
| Mar 31, 2022 | 8.74% |
| Dec 31, 2021 | -360.76% |
| Sep 30, 2021 | 24.64% |
| Jun 30, 2021 | 10.45% |
| Mar 31, 2021 | -7.57% |
| Dec 31, 2020 | -9.95% |
| Sep 30, 2020 | 59.74% |
| Jun 30, 2020 | -35.13% |
| Mar 31, 2020 | -24.39% |
| Dec 31, 2019 | -47.92% |
| Sep 30, 2019 | -70.24% |
| Jun 30, 2019 | -20.95% |
| Mar 31, 2019 | 14.94% |